DT
BPMC

Diversified Trust’s Blueprint Medicines BPMC Stock Holding History

Diversified Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,354
Closed -$1.2M – 1004
2025
Q2 		$1.2M Sell
9,354
-5,872
-39% -$610K 0.03% 343
2025
Q1 		$1.35M Buy
15,226
+7,808
+105% +$762K 0.03% 287
2024
Q4 		$647K Sell
7,418
-8,258
-53% -$756K 0.02% 515
2024
Q3 		$1.45M Sell
15,676
-234
-1% -$23.2K 0.04% 283
2024
Q2 		$1.71M Buy
15,910
+1,438
+10% +$144K 0.05% 230
2024
Q1 		$1.37M Buy
14,472
+498
+4% +$42.7K 0.04% 254
2023
Q4 		$1.29M Buy
13,974
+2,755
+25% +$179K 0.04% 235
2023
Q3 		$563K Buy
11,219
+318
+3% +$17K 0.02% 426
2023
Q2 		$689K Buy
10,901
+52
+0.5% +$2.83K 0.03% 373
2023
Q1 		$488K Buy
10,849
+3,405
+46% +$153K 0.02% 469
2022
Q4 		$326K Buy
7,444
+24
+0.3% +$1.15K 0.01% 552
2022
Q3 		$489K Sell
7,420
-198
-3% -$12.7K 0.02% 402
2022
Q2 		$385K Hold
7,618
– – 0.02% 483
2022
Q1 		$487K Hold
7,618
– – 0.02% 462
2021
Q4 		$816K Buy
7,618
+3,115
+69% +$326K 0.03% 305
2021
Q3 		$463K Buy
+4,503
New +$419K 0.02% 427

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Diversified Trust's BPMC Position: Q3 2025 in Review

Diversified Trust sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 9,354 shares — an estimated $1.2M sold.

Diversified Trust first reported a position in BPMC in Q3 2021 and held it in 16 quarters. The position peaked at $1.71M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Diversified Trust reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Diversified Trust sold 9,354 Blueprint Medicines shares in Q3 2025, an estimated $1.2M.
  • Diversified Trust first reported a position in Blueprint Medicines in Q3 2021 and held it in 16 quarters.
  • Diversified Trust's Blueprint Medicines position peaked at $1.71M in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Diversified Trust's 13F filing for Q3 2025, filed 20 Oct 2025.